Today's Technical View on AstraZeneca, GlaxoSmithKline, PDL BioPharma, and Herbalife

Mon Apr 1, 2013 8:01am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130401:nPn4018644


LONDON,  April 1, 2013  /PRNewswire/ --

One of the biggest trends to emerge in the healthcare sector in the last year
has been increasing competition from generic drugs. In 2012, patent on several
blockbuster drugs expired, leading to increasing generic competition for drug
manufacturers such as AstraZeneca Plc (NYSE: AZN), GlaxoSmithKline Plc (NYSE:
GSK), and PDL BioPharma Inc. (NASDAQ: PDLI). The trend is expected to continue
in 2013. The key for drug manufacturers will be to boost their product pipeline.
Innovation will also be important for drug related products manufacturers such
as Herbalife Ltd. (NYSE: HLF). On Thursday, healthcare stocks ended mostly
higher, tracking gains in the broad market. StockCall initiated free in-depth
technical analysis on AZN, GSK, PDLI, and HLF which are currently available upon
sign up at

http://www.stockcall.com/research

Shares of AstraZeneca Plc rose sharply in Thursday's trading session. The stock
rose to an intra-day high of  $50.12  before finishing the day 1.54% higher at 
$49.98. AstraZeneca's shares are currently trading close to their 52-week high
of  $50.14. The stock has had an excellent run so far in 2013, gaining more than
10%. The company's shares currently have a dividend yield of 7.60%. The
company's shares have seen a series of highs in the last few sessions, which is
a bullish signal. The stock has also broken through  $47.50  resistance level,
which further confirms the upbeat trend. Sign up for the free technical analysis
on AZN at

http://www.StockCall.com/AZN040113.pdf

GlaxoSmithKline Plc's shares are also currently trading near their 52-week high
of  $47.69. On Thursday, the stock touched an intra-day high of  $47.08  before
finishing the day 1.14% higher at  $46.91. GlaxoSmithKline's shares have gained
more than 9.50% in 2013 so far, compared to a gain of more than 10% for the S&P
500. The company currently has a dividend yield of 5.88%. The company's shares
have been gaining momentum over the past few trading sessions which indicate
that market sentiment is bullish on the stock. The positive trend is further
confirmed by the stock's MACD chart. Download the free report on GSK by
registering at

http://www.StockCall.com/GSK040113.pdf

PDL BioPharma Inc. is one of the highest divided yielding stocks in the
healthcare sector. The stock currently has a dividend yield of 8.22%. Shares of
PDL BioPharma edged higher in trading on Thursday. The stock closed 0.97% higher
at  $7.30  after touching an intra-day high of  $7.34. The company's shares are
currently trading nearly 10% below their 52-week high of  $8.09. The stock has
seen a series of highs since February. The stock is also trading above its
50-day and 200-day moving averages, which is a bullish signal. The stock's MACD
is currently trading above the signal line and the zero-line, further confirming
the positive trend. The free report on PDLI can be downloaded by signing up now
at

http://www.StockCall.com/PDLI040113.pdf

Shares of Herbalife Ltd. struggled in trading on Thursday even as the broad
market edged higher. The stock ended the day 0.87% lower at  $37.45  after
touching an intra-day low of  $37.24. Herbalife's shares are trading nearly 50%
below their 52-week high of  $73. The stock, however, has had a decent run so
far this year. Year-to-date, shares of HLF have gained more than 14.50%.
Herbalife currently has a dividend yield of 3.20%. The company's shares are
currently trading below their 50-day and 200-day moving averages, which is a
bearish signal. The downbeat trend is further confirmed by the stock's MACD
chart. Herbalife Ltd's shares have support at around  $37. Free report on HLF
can be accessed by registering at

http://www.StockCall.com/HLF040113.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at

http://www.stockcall.com   

SOURCE  StockCall.com


Contact Person:William T. Knight, Email: info@stockcall.com , Contact Number:
+1(646)396-9857 (9:00 am EST - 01:30 pm EST)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.